May 18, 2020

SAN RAMON, Calif., May 18, 2020—CooperVision has announced that its new Biofinity® toric multifocal contact lenses are now available nationwide in the United States.

“Amid the COVID-19 pandemic, we understand that eye care practices are operating under various circumstances, and for many, fitting contact lenses still may not be possible,” said Jerry Warner, President, Americas and Global Commercial Functions, CooperVision. “Despite the current challenges, we’re able to bring Biofinity® toric multifocal fully to market. When practice doors are open again, and eye care professionals have patients back in the chair, Biofinity® toric multifocal lenses will provide an easy-to-fit, advanced lens design for their astigmatic presbyopes—patients for whom contact lens wear was previously a challenge.”

Biofinity® toric multifocal combines the comfort and leading optical designs of Biofinity® toric—the most prescribed toric lens on the market1—and Balanced Progressive Technology® from Biofinity® multifocal that has four distinct ADD powers for more accurate fitting. Like all Biofinity® silicone hydrogel lenses, Biofinity® toric multifocal features CooperVision’s Aquaform® Technology, which offers superb breathability and higher moisture content to keep eyes comfortable and healthy.

CooperVision’s made-to-order advantage results in more than 200,000 prescription options2 to ensure eye care professionals have the lens they need for each individual patient, resulting in the right fit, the first time. In fact, studies of Biofinity® toric multifocal showed a 93% success rate on initial fitting when using the fitting guide.3 Fitting is even easier with the toric and multifocal fitting calculator in CooperVision’s OptiExpert app, which will be updated in early June and is free to download in the App Store and Google Play, or can be accessed on the web.

Early feedback from eye care professionals fitting the lens has been positive.

“Biofinity® toric multifocal has exceeded my expectations with every patient I have had the opportunity to fit with it so far,” said Harmin Chima, OD, who practices at Family First Vision Care in Lyndhurst, Ohio. “Patients reported incredible comfort—a quality I have come to expect from all Biofinity® lenses—as well as the stability we appreciate in Biofinity® toric. I have also been impressed with patient feedback on both distance and near vision with the first trial pair.”

“I’m a firm believer that anyone who wants to wear contact lenses and is a good candidate for doing so should have the option. Biofinity® toric multifocal is an innovative lens that equips me with the technology to help make that happen,” Dr. Chima continued.

Biofinity® toric multifocal lenses are available in sphere powers from +10.00 to -10.00 (0.50 steps after +/-6.00D), with cylinder powers from -0.75 to -5.75 (0.50 steps), an axis of 5 degrees to 180 degrees in 5-degree steps, and ADD powers of +1.00, +1.50, +2.00, and +2.50, with each ADD available in a D and N lens.

For more information, visit


# # #


1 CVI data on file, 2019. US industry reports and internal estimates.

2 CVI data on file 2019. Based on total number of prescription option combinations manufactured (for sphere, cylinder, axis and add – including D & N combinations).

3 CVI Data on file 2018. Non-dispensing, subject masked, randomized, bilateral, cross-over short-term clinical evaluation. 27 astigmatic, presbyopic soft CL wearers at 2 sites (UK & US) fitted using CVI fit guide.

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit

About CooperCompanies
CooperCompanies (“Cooper”) is a global medical device company public traded on NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit

Media Contact
Heather Kowalczyk
McDougall Communications for CooperVision, Inc. or +1-585-434-2148